{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T21:50:15Z","timestamp":1776289815221,"version":"3.50.1"},"reference-count":49,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Research Grant of Jagiellonian University Medical College","award":["N41\/DBS\/000687"],"award-info":[{"award-number":["N41\/DBS\/000687"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>The SARS-CoV-2 pandemic presents a broad clinical spectrum from asymptomatic cases to severe respiratory failure with high mortality. Severe COVID-19 is characterized by immune dysregulation, including lymphopenia and alterations in the counts of T, B, and NK cells in peripheral blood. Due to the limited data on long-term outcomes related to immune dysregulation, we aimed to analyze immunologic features at baseline in severe and mild COVID-19 cases and assess follow-up characteristics associated with later mortality and long-COVID signs. We included adult patients consecutively hospitalized with COVID-19 between June and November 2020 at the University Hospital in Krak\u00f3w, corresponding to the first and second waves of COVID-19 in Poland. We enrolled only those who had been thoroughly assessed in terms of clinic and laboratory data, including immunological workups, and survived the acute phase of the disease. In 2025, between February and April (median time of follow-up: 54 months), we conducted a telephone questionnaire on long-COVID symptoms among survivors who had given their consent. Statistical analyses were performed to compare groups with severe and mild disease in terms of dysregulation in lymphocyte subpopulations and the follow-up outcomes. The study included 103 COVID-19 patients, comprising 53 severe (based on the need for at least high-flow nasal oxygen therapy) and 50 mild cases, with no differences in age, sex, and body mass index. Severe COVID-19 patients compared to mild cases had lower CD3+ T cells (count and percentage), CD4+ T cells (count and percentage), CD8+ T cells (count), and NK cells (count), but higher CD19+ B cells (percentage) at baseline (p &lt; 0.05, all). At the time of follow-up, we evaluated 80 patients (77.7% of the baseline participants), with 23 (22.3%) patients lost to follow-up. Among patients analyzed in the follow-up, 23 (28.8%) had died, and 29 of the 57 survivors (50.9%) reported persistent long-COVID symptoms. Patients who died had significantly lower baseline counts of CD3+ T cells (377 vs. 655 cells\/\u00b5L), CD4+ T cells (224 vs. 372 cells\/\u00b5L), CD8+ T cells (113 vs. 188 cells\/\u00b5L), and NK cells (118 vs. 157 cells\/\u00b5L) compared to survivors (p &lt; 0.05, all). Notably, the percentage of CD19+ B cells was higher in deceased individuals (19.2% vs. 13.5%; p = 0.049). In contrast, we did not document differences in baseline immunological data among survivors with and without long-COVID signs. Our study suggests that dysregulation in lymphocyte subpopulations during the COVID-19 acute phase may be associated with increased late mortality, but not with the persistence of long-COVID symptoms.<\/jats:p>","DOI":"10.3390\/v17101400","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:42:03Z","timestamp":1761054123000},"page":"1400","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Baseline Dysregulation in B, T, and NK Cells in COVID-19 Predicts Increased Late Mortality but Not Long-COVID Symptoms: Results from a Single-Center Observational Study"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4038-5016","authenticated-orcid":false,"given":"Aleksandra","family":"Matyja-Bednarczyk","sequence":"first","affiliation":[{"name":"Jagiellonian University Medical College, Prof A. Szczeklik 2nd Chair of Internal Medicine, Department of Allergy, Autoimmunization and Hypercoagulation, Jakubowskiego 2, 30-668 Krak\u00f3w, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0321-3557","authenticated-orcid":false,"given":"Rados\u0142aw","family":"Dziedzic","sequence":"additional","affiliation":[{"name":"Jagiellonian University Medical College, Doctoral School of Medical and Health Sciences, \u015bw. \u0141azarza 16, 31-530 Krak\u00f3w, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5556-2637","authenticated-orcid":false,"given":"Anna","family":"Drynda","sequence":"additional","affiliation":[{"name":"Jagiellonian University Medical College, Doctoral School of Medical and Health Sciences, \u015bw. \u0141azarza 16, 31-530 Krak\u00f3w, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1285-1267","authenticated-orcid":false,"given":"Ada","family":"Gradzikiewicz","sequence":"additional","affiliation":[{"name":"University Hospital in Krak\u00f3w, Department of Rheumatology, Immunology and Internal Medicine, Jakubowskiego 2, 30-688 Krak\u00f3w, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6474-0177","authenticated-orcid":false,"given":"Monika","family":"Boci\u0105ga-Jasik","sequence":"additional","affiliation":[{"name":"Jagiellonian University Medical College, Department of Infectious and Tropical Diseases, Jakubowskiego 2, 30-668 Krak\u00f3w, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9786-2499","authenticated-orcid":false,"given":"Krzysztof","family":"W\u00f3jcik","sequence":"additional","affiliation":[{"name":"Jagiellonian University Medical College, Prof A. Szczeklik 2nd Chair of Internal Medicine, Department of Allergy, Autoimmunization and Hypercoagulation, Jakubowskiego 2, 30-668 Krak\u00f3w, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7008-2492","authenticated-orcid":false,"given":"Sabina","family":"Licho\u0142ai","sequence":"additional","affiliation":[{"name":"Jagiellonian University Medical College, Prof A. Szczeklik 2nd Chair of Internal Medicine, Department of Molecular Biology and Clinical Genetics, Skawi\u0144ska 8, 31-066 Krak\u00f3w, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6404-7233","authenticated-orcid":false,"given":"Karolina","family":"G\u00f3rka","sequence":"additional","affiliation":[{"name":"Jagiellonian University Medical College, Prof A. Szczeklik 2nd Chair of Internal Medicine, Department of Pulmonology, Jakubowskiego 2, 30-668 Krak\u00f3w, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2770-8669","authenticated-orcid":false,"given":"Natalia","family":"Celejewska-W\u00f3jcik","sequence":"additional","affiliation":[{"name":"Jagiellonian University Medical College, Prof A. Szczeklik 2nd Chair of Internal Medicine, Department of Pulmonology, Jakubowskiego 2, 30-668 Krak\u00f3w, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4178-6914","authenticated-orcid":false,"given":"Tomasz","family":"Stachura","sequence":"additional","affiliation":[{"name":"Jagiellonian University Medical College, Prof A. Szczeklik 2nd Chair of Internal Medicine, Department of Pulmonology, Jakubowskiego 2, 30-668 Krak\u00f3w, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0777-9785","authenticated-orcid":false,"given":"Kamil","family":"Polok","sequence":"additional","affiliation":[{"name":"Jagiellonian University Medical College, Department of Intensive Care and Perioperative Medicine, Jakubowskiego 2, 30-668 Krak\u00f3w, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2221-614X","authenticated-orcid":false,"given":"Lech","family":"Zar\u0119ba","sequence":"additional","affiliation":[{"name":"University of Rzesz\u00f3w, Faculty of Exact and Technical Science, Institute of Computer Science, Pigonia 1, 35-310 Rzesz\u00f3w, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9796-9242","authenticated-orcid":false,"given":"Teresa","family":"Iwaniec","sequence":"additional","affiliation":[{"name":"Jagiellonian University Medical College, Department of Hematology, Jakubowskiego 2, 30-688 Krak\u00f3w, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7012-4613","authenticated-orcid":false,"given":"Krzysztof","family":"S\u0142adek","sequence":"additional","affiliation":[{"name":"Jagiellonian University Medical College, Prof A. Szczeklik 2nd Chair of Internal Medicine, Department of Pulmonology, Jakubowskiego 2, 30-668 Krak\u00f3w, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9634-0963","authenticated-orcid":false,"given":"Stanis\u0142awa","family":"Bazan-Socha","sequence":"additional","affiliation":[{"name":"Jagiellonian University Medical College, Prof A. Szczeklik 2nd Chair of Internal Medicine, Department of Allergy, Autoimmunization and Hypercoagulation, Jakubowskiego 2, 30-668 Krak\u00f3w, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(21)02796-3","article-title":"Estimating Excess Mortality Due to the COVID-19 Pandemic: A Systematic Analysis of COVID-19-Related Mortality, 2020\u20132021","volume":"399","author":"Wang","year":"2022","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical Features of Patients Infected with 2019 Novel Coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Elrashdy, F., Redwan, E.M., and Uversky, V.N. (2020). Why COVID-19 Transmission Is More Efficient and Aggressive Than Viral Transmission in Previous Coronavirus Epidemics?. Biomolecules, 10.","DOI":"10.20944\/preprints202009.0076.v1"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Shang, W., Kang, L., Cao, G., Wang, Y., Gao, P., Liu, J., and Liu, M. (2022). Percentage of Asymptomatic Infections among SARS-CoV-2 Omicron Variant-Positive Individuals: A Systematic Review and Meta-Analysis. Vaccines, 10.","DOI":"10.3390\/vaccines10071049"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00508-020-01760-4","article-title":"Clinical Manifestations of COVID-19 in the General Population: Systematic Review","volume":"133","year":"2021","journal-title":"Wien. Klin. Wochenschr."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Katzenschlager, S., Zimmer, A.J., Gottschalk, C., Grafeneder, J., Schmitz, S., Kraker, S., Ganslmeier, M., Muth, A., Seitel, A., and Maier-Hein, L. (2021). Can We Predict the Severe Course of COVID-19\u2014A Systematic Review and Meta-Analysis of Indicators of Clinical Outcome?. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0255154"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/jmv.25871","article-title":"C-reactive Protein Correlates with Computed Tomographic Findings and Predicts Severe COVID-19 Early","volume":"92","author":"Tan","year":"2020","journal-title":"J. Med. Virol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.5005\/jp-journals-10071-23706","article-title":"Prognostic Value of Serum Procalcitonin in COVID-19 Patients: A Systematic Review","volume":"25","author":"Hoodbhoy","year":"2021","journal-title":"Indian J. Crit. Care Med."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Kojima, K., Yoon, H., Okishio, K., and Tsuyuguchi, K. (2023). Increased Lactate Dehydrogenase Reflects the Progression of COVID-19 Pneumonia on Chest Computed Tomography and Predicts Subsequent Severe Disease. Sci. Rep., 13.","DOI":"10.1038\/s41598-023-28201-2"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1161\/ATVBAHA.120.314872","article-title":"Prevalence and Outcomes of D-Dimer Elevation in Hospitalized Patients With COVID-19","volume":"40","author":"Berger","year":"2020","journal-title":"ATVB"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Wang, X., Tang, G., Liu, Y., Zhang, L., Chen, B., Han, Y., Fu, Z., Wang, L., Hu, G., and Ma, Q. (2022). The Role of IL-6 in Coronavirus, Especially in COVID-19. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.1033674"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12985-022-01926-8","article-title":"Characteristics of Lymphocyte Subset Alterations in COVID-19 Patients with Different Levels of Disease Severity","volume":"19","author":"Dai","year":"2022","journal-title":"Virol. J."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Clavarino, G., Leroy, C., Epaulard, O., Raskovalova, T., Vilotitch, A., Pernollet, M., Dumestre-P\u00e9rard, C., Defendi, F., Le Mar\u00e9chal, M., and Le Gouellec, A. (2022). Fine Analysis of Lymphocyte Subpopulations in SARS-CoV-2 Infected Patients: Differential Profiling of Patients With Severe Outcome. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.889813"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0140-6736(24)01136-X","article-title":"Long COVID: A Clinical Update","volume":"404","author":"Greenhalgh","year":"2024","journal-title":"Lancet"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Fresi, E., Pagani, E., Pezzetti, F., Montomoli, C., Monti, C., Betti, M., De Silvestri, A., Sagliocco, O., Zuccaro, V., and Bruno, R. (2025). Long COVID\u2019s Hidden Complexity: Machine Learning Reveals Why Personalized Care Remains Essential. JCM, 14.","DOI":"10.20944\/preprints202505.0020.v1"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Rutkowska, E., Kwiecie\u0144, I., \u017babicka, M., Maliborski, A., Raniszewska, A., K\u0142os, K., Urba\u0144ska, W., Klajnowicz, I., Rzepecki, P., and Chcia\u0142owski, A. (2021). Cytokines and Leukocytes Subpopulations Profile in SARS-CoV-2 Patients Depending on the CT Score Severity. Viruses, 13.","DOI":"10.3390\/v13050880"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/jmv.26232","article-title":"The Cytokine Storm and COVID-19","volume":"93","author":"Hu","year":"2021","journal-title":"J. Med. Virol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s40249-020-00723-1","article-title":"Abnormal Immunity of Non-Survivors with COVID-19: Predictors for Mortality","volume":"9","author":"Zhao","year":"2020","journal-title":"Infect. Dis. Poverty"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Andrejkovits, \u00c1.V., Hu\u021banu, A., Manu, D.R., Dobreanu, M., and V\u0103sie\u0219iu, A.M. (2024). Dynamic Changes in Lymphocyte Populations and Their Relationship with Disease Severity and Outcome in COVID-19. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms252211921"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e176640","DOI":"10.1172\/JCI176640","article-title":"Integrated Longitudinal Multiomics Study Identifies Immune Programs Associated with Acute COVID-19 Severity and Mortality","volume":"134","author":"Gygi","year":"2024","journal-title":"J. Clin. Investig."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jinf.2023.02.025","article-title":"Persistent Dysregulation of Cellular Immunity Following COVID-19 Recovery despite Minimal Post-COVID-19 Sequelae Manifestation","volume":"86","author":"Putri","year":"2023","journal-title":"J. Infect."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"eadi9379","DOI":"10.1126\/sciadv.adi9379","article-title":"Spontaneous, Persistent, T Cell\u2013Dependent IFN-\u03b3 Release in Patients Who Progress to Long Covid","volume":"10","author":"Krishna","year":"2024","journal-title":"Sci. Adv."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.immuni.2022.01.017","article-title":"Immuno-Proteomic Profiling Reveals Aberrant Immune Cell Regulation in the Airways of Individuals with Ongoing Post-COVID-19 Respiratory Disease","volume":"55","author":"Vijayakumar","year":"2022","journal-title":"Immunity"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41586-023-06651-y","article-title":"Distinguishing Features of Long COVID Identified through Immune Profiling","volume":"623","author":"Klein","year":"2023","journal-title":"Nature"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Balzanelli, M.G., Distratis, P., Dipalma, G., Vimercati, L., Catucci, O., Amatulli, F., Cefalo, A., Lazzaro, R., Palazzo, D., and Aityan, S.K. (2021). Immunity Profiling of COVID-19 Infection, Dynamic Variations of Lymphocyte Subsets, a Comparative Analysis on Four Different Groups. Microorganisms, 9.","DOI":"10.3390\/microorganisms9102036"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1080\/23744235.2021.1924397","article-title":"Long COVID or Post-COVID-19 Syndrome: Putative Pathophysiology, Risk Factors, and Treatments","volume":"53","author":"Yong","year":"2021","journal-title":"Infect. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/s41467-021-27797-1","article-title":"Immunoglobulin Signature Predicts Risk of Post-Acute COVID-19 Syndrome","volume":"13","author":"Cervia","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Bellan, M., Apostolo, D., Alb\u00e8, A., Crevola, M., Errica, N., Ratano, G., Tonello, S., Minisini, R., D\u2019Onghia, D., and Baricich, A. (2022). Determinants of Long COVID among Adults Hospitalized for SARS-CoV-2 Infection: A Prospective Cohort Study. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.1038227"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Noviello, M., De Lorenzo, R., Chimienti, R., Maugeri, N., De Lalla, C., Siracusano, G., Lor\u00e8, N.I., Rancoita, P.M.V., Cugnata, F., and Tassi, E. (2024). The Longitudinal Characterization of Immune Responses in COVID-19 Patients Reveals Novel Prognostic Signatures for Disease Severity, Patients\u2019 Survival and Long COVID. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1381091"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.bbi.2024.12.006","article-title":"A Two-Year Cohort Study Examining the Impact of Cytokines and Chemokines on Cognitive and Psychiatric Outcomes in Long-COVID-19 Patients","volume":"124","author":"Roncete","year":"2025","journal-title":"Brain Behav. Immun."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Ruytinx, P., Vandormael, P., Fraussen, J., Pieters, Z., Thonissen, S., Hellings, N., Stinissen, P., Callebaut, I., Penders, J., and Vanhove, K. (2023). Comprehensive Antibody and Cytokine Profiling in Hospitalized COVID-19 Patients in Relation to Clinical Outcomes in a Large Belgian Cohort. Sci. Rep., 13.","DOI":"10.1038\/s41598-023-46421-4"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Mohan, A., Iyer, V.A., Kumar, D., Batra, L., and Dahiya, P. (2023). Navigating the Post-COVID-19 Immunological Era: Understanding Long COVID-19 and Immune Response. Life, 13.","DOI":"10.3390\/life13112121"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Maltezou, H.C., Pavli, A., and Tsakris, A. (2021). Post-COVID Syndrome: An Insight on Its Pathogenesis. Vaccines, 9.","DOI":"10.3390\/vaccines9050497"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1080\/07853890.2022.2076901","article-title":"Pathophysiology and Mechanism of Long COVID: A Comprehensive Review","volume":"54","author":"Chalon","year":"2022","journal-title":"Ann. Med."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Tsilingiris, D., Vallianou, N.G., Karampela, I., Christodoulatos, G.S., Papavasileiou, G., Petropoulou, D., Magkos, F., and Dalamaga, M. (2023). Laboratory Findings and Biomarkers in Long COVID: What Do We Know So Far? Insights into Epidemiology, Pathogenesis, Therapeutic Perspectives and Challenges. Int. J. Mol. Sci., 24.","DOI":"10.20944\/preprints202305.1487.v1"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41590-021-01113-x","article-title":"Immunological Dysfunction Persists for 8 Months Following Initial Mild-to-Moderate SARS-CoV-2 Infection","volume":"23","author":"Phetsouphanh","year":"2022","journal-title":"Nat. Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"LaVergne, S.M., Dutt, T.S., McFann, K., Baxter, B.A., Webb, T.L., Berry, K., Tipton, M., Stromberg, S., Sullivan, B.M., and Dunn, J. (2024). Persistent CD8+ T Cell Proliferation and Activation in COVID-19 Adult Survivors with Post-Acute Sequelae: A Longitudinal, Observational Cohort Study of Persistent Symptoms and T Cell Markers. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1303971"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/j.vaccine.2023.02.008","article-title":"Protective Effect of COVID-19 Vaccination against Long COVID Syndrome: A Systematic Review and Meta-Analysis","volume":"41","author":"Watanabe","year":"2023","journal-title":"Vaccine"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1093\/cid\/ciac630","article-title":"Reduced Incidence of Long Coronavirus Disease Referrals to the Cambridge University Teaching Hospital Long Coronavirus Disease Clinic","volume":"76","author":"Krishna","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"ofac464","DOI":"10.1093\/ofid\/ofac464","article-title":"Risk of Long COVID in People Infected With Severe Acute Respiratory Syndrome Coronavirus 2 After 2 Doses of a Coronavirus Disease 2019 Vaccine: Community-Based, Matched Cohort Study","volume":"9","author":"Ayoubkhani","year":"2022","journal-title":"Open Forum Infect. Dis."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41541-022-00526-5","article-title":"Association between BNT162b2 Vaccination and Reported Incidence of Post-COVID-19 Symptoms: Cross-Sectional Study 2020\u201321, Israel","volume":"7","author":"Kuodi","year":"2022","journal-title":"npj Vaccines"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/s41591-022-01840-0","article-title":"Long COVID after Breakthrough SARS-CoV-2 Infection","volume":"28","author":"Bowe","year":"2022","journal-title":"Nat. Med."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Sosa-Hern\u00e1ndez, V.A., Torres-Ru\u00edz, J., Cervantes-D\u00edaz, R., Romero-Ram\u00edrez, S., P\u00e1ez-Franco, J.C., Meza-S\u00e1nchez, D.E., Ju\u00e1rez-Vega, G., P\u00e9rez-Fragoso, A., Ortiz-Navarrete, V., and Ponce-de-Le\u00f3n, A. (2020). B Cell Subsets as Severity-Associated Signatures in COVID-19 Patients. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.611004"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Mendez-Cortina, Y., Rodriguez-Perea, A.L., Chvatal-Medina, M., Lopera, T.J., Alvarez-Mesa, N., Rodas-Mar\u00edn, J.K., Moncada, D.C., Rugeles, M.T., and Velilla, P.A. (2022). Dynamics of Humoral Immune Response in SARS-CoV-2 Infected Individuals with Different Clinical Stages. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.1007068"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1136\/postgradmedj-2021-140540","article-title":"Memory B Cells and Serum Immunoglobulins Are Associated with Disease Severity and Mortality in Patients with COVID-19","volume":"98","author":"Kurt","year":"2022","journal-title":"Postgrad. Med. J."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.thromres.2023.01.016","article-title":"Decreased Protein C Activity, Lower ADAMTS13 Antigen and Free Protein S Levels Accompanied by Unchanged Thrombin Generation Potential in Hospitalized COVID-19 Patients","volume":"223","author":"Polok","year":"2023","journal-title":"Thromb. Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"072","DOI":"10.1055\/s-0041-1728832","article-title":"COVID-19 and Antiphospholipid Antibodies: Time for a Reality Check?","volume":"48","author":"Favaloro","year":"2022","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"10760296221102940","DOI":"10.1177\/10760296221102940","article-title":"Validation of the PESI Scale to Predict In-Hospital Mortality in Patients with Pulmonary Thromboembolism Secondary to SARS CoV\u22122 Infection","volume":"28","year":"2022","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"ref_49","first-page":"e68767","article-title":"Thromboembolic Disease and COVID-19: Experience of a University and Emergency Hospital During the Pandemic","volume":"16","author":"Stefan","year":"2024","journal-title":"Cureus"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/17\/10\/1400\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T01:08:22Z","timestamp":1761095302000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/17\/10\/1400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":49,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["v17101400"],"URL":"https:\/\/doi.org\/10.3390\/v17101400","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,21]]}}}